References
- King TD, Mills NL. Nonoperative closure of atrial septal defect. Surgery 1976; 75: 383-8.
- Rao PS. History of atrial septal occlusion devices. In Rao PS and Kern MJ: Catheter based devices: for the treatment of non-coronary cardiovascular disease in adults and children. Philadelphia: Lippincott Williams & Wikins; 2003. p. 3-9.
- Majunke N, Sievert H. ASD/PFO Devices: What Is in the Pipeline? J Intervent Cardiol 2007; 20: 517-23.
- Pavcnik D, Wright KC, Wallace S. Monodisk: device for percutaneous transcatheter closure of cardiac septal defects. Cardiovasc Intervent Radiol 1993; 16: 308-12.
- Kim MS, Klein AJ, Carroll JD. Transcatheter closure of intracardiac defects in adults. J Interv Cardiol 2007; 20: 524-45.
- Pavcnik D, Tekulve K, Uchida B, Pavcnik Arnol M, Van Alstine WG, Keller FS, et al. Biodisk: a new device for closure of patent foramen ovale. Catheter Cardiovasc Interv 2010; 75: 861-7.
- Ni RF, Kranokpiraksa P, Pavcnik D, Kakizawa H, Uchida BT, Keller FS, et al. Testing percutaneous arterial closure devices: An animal model. Cardiovasc Intervent Radiol 2009; 32: 313-6.
- Uchida BT, Pavcnik D, Shimohira M, Choi YH, Jeromel M, Keller FS, et al. New coaxial transseptal needle for creation of atrial septal defects in adult sheep. Cardiovasc Intervent Radiol 2011; 34: 620-5.
- Kranokpiraksa P, Pavcnik D, Kakizawa H, Uchida BT, Jeromel M, Keller FS, et al. Hemostatic efficacy of chitosan-based bandage for closure of percutaneous arterial access sites: An experimental study in heparinized sheep model. Radiol Oncol 2010; 44: 86-91.
- Wei Lu, Pavcnik D, Uchida B, Park WK, Liu L, Timmermans HA, et al. The ovine jugular vein as a model for interventional radiology procedures. Radiol Oncol 2008; 42: 59-65.
- Jeromel P, Pavcnik D. Infrahepatic caudal/inferior vena cava interruption with azygos/hemiazygos continuation. Vascular anomaly in swine. Radiol Oncol 2010; 44: 149-52.
- Narayanawamy M, Wright KC, Kandarpa K. Animal models for atherosclerosis, restenosis, and endovascular graft research. J Vasc Interv Radiol 2000; 11: 5-17.
- Badylak SF. The extracellular matrix as a biologic scaffold material. Biomaterials 2007; 28: 3587-93.
- Jux C, Bertram H, Wohlsein P, Bruegmann M, Paul T. Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: development and preclinical evaluation of the BioSTAR device. J Am Coll Cardiol 2006; 48: 161-9.
- Hoehn R, Hesse C, Ince H, Peuster M. First experience with the biostar-device for various applications in pediatric patients with congenital heart disease. Catheter Cardiovasc Interv 2010; 75: 72-7.
- Morgan G, Lee KJ, Charturvedi R, Benson L. A biodegradable device (Biostar) for atrial septal defect in children Catheter Cardiovasc Interv 2010; 76: 241-5.
- Mullen MJ, Hildick-Smith D, De Giovanni JV, Duke C. BioSTAR evaluation study (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-levels shunts. Circulation 2006; 114:1962-7.